Delivery Order SPE2DB22D1017-SPE2DB25FYPBF
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Orencia 125 mg/ml syringes valued at $14,495.04. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of...
- The Defense Logistics Agency awarded a $11,893.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Orencia 125 mg/ml syringes. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $3,570.63 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of August 12, 2025. This non-set-aside, firm fixed-price contract was competitively awarded on August 11, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. Orencia (abatacept) is a biologic immunosuppressant used primarily to treat rheumatoid arthritis and other autoimmune conditions, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $8,215.15 to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,445.94 to AmerisourceBergen Drug Corp for the supply of Orencia 125 mg/ml syringes. This competitive, firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, was issued without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its corporate office location in the same municipality. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORENCIA 125 mg/ml syringes valued at $7,399.65 on August 19, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $5,590.59 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Orencia 125 mg/ml syringes. This competitively awarded, firm fixed-price contract is not set-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be executed from the contractor's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Orencia 250 mg vials, valued at $4,283.82. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is set to complete by July 25, 2025. Orencia (abatacept) is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions, reflecting the agency's ongoing procurement of specialty pharmaceuticals to support military...
- The Defense Logistics Agency awarded a $6,473.76 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at the same address. Orencia (abatacept)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orencia 125 mg/mL syringes, valued at $3,701.46. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...